Annual CFO
-$118.00 M
-$5.12 M-4.53%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual cash flow from operations is -$118.00 million, with the most recent change of -$5.12 million (-4.53%) on December 31, 2023.
- During the last 3 years, MRNS annual CFO has fallen by -$57.09 million (-93.72%).
- MRNS annual CFO is now -9506.07% below its all-time high of -$1.23 million, reached on December 31, 2012.
Performance
MRNS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$19.45 M
+$11.39 M+36.92%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly cash flow from operations is -$19.45 million, with the most recent change of +$11.39 million (+36.92%) on September 30, 2024.
- Over the past year, MRNS quarterly CFO has stayed the same.
- MRNS quarterly CFO is now -460.04% below its all-time high of $5.40 million, reached on September 30, 2021.
Performance
MRNS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$114.75 M
+$5.72 M+4.75%
September 30, 2024
Summary
- As of February 8, 2025, MRNS TTM cash flow from operations is -$114.75 million, with the most recent change of +$5.72 million (+4.75%) on September 30, 2024.
- Over the past year, MRNS TTM CFO has stayed the same.
- MRNS TTM CFO is now -16315.88% below its all-time high of -$699.00 thousand, reached on March 31, 2013.
Performance
MRNS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MRNS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.5% | 0.0% | 0.0% |
| 3 y3 years | -93.7% | +11.2% | -1.6% |
| 5 y5 years | -323.8% | +11.2% | -1.6% |
MRNS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -112.7% | at low | at high | +53.1% | -106.8% | +9.4% |
| 5 y | 5-year | -142.6% | at low | -460.0% | +53.1% | -135.9% | +9.4% |
| alltime | all time | -9506.1% | at low | -460.0% | +53.1% | <-9999.0% | +9.4% |
Marinus Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$19.45 M(-36.9%) | -$114.75 M(-4.7%) |
| Jun 2024 | - | -$30.84 M(-17.7%) | -$120.47 M(+5.7%) |
| Mar 2024 | - | -$37.46 M(+38.8%) | -$113.98 M(-3.4%) |
| Dec 2023 | -$118.00 M(+4.5%) | -$26.99 M(+7.2%) | -$118.00 M(+4.5%) |
| Sep 2023 | - | -$25.17 M(+3.3%) | -$112.92 M(-3.8%) |
| Jun 2023 | - | -$24.36 M(-41.3%) | -$117.39 M(-7.4%) |
| Mar 2023 | - | -$41.48 M(+89.3%) | -$126.71 M(+12.2%) |
| Dec 2022 | -$112.89 M(+103.5%) | -$21.91 M(-26.1%) | -$112.89 M(+0.1%) |
| Sep 2022 | - | -$29.64 M(-12.0%) | -$112.72 M(+45.1%) |
| Jun 2022 | - | -$33.67 M(+21.8%) | -$77.67 M(+16.0%) |
| Mar 2022 | - | -$27.66 M(+27.1%) | -$66.96 M(+20.7%) |
| Dec 2021 | -$55.48 M(-8.9%) | -$21.75 M(-502.6%) | -$55.48 M(+10.7%) |
| Sep 2021 | - | $5.40 M(-123.5%) | -$50.13 M(-28.4%) |
| Jun 2021 | - | -$22.95 M(+41.9%) | -$70.00 M(+11.0%) |
| Mar 2021 | - | -$16.18 M(-1.4%) | -$63.05 M(+3.5%) |
| Dec 2020 | -$60.91 M(+25.2%) | -$16.40 M(+13.3%) | -$60.91 M(+0.2%) |
| Sep 2020 | - | -$14.47 M(-9.6%) | -$60.76 M(+4.2%) |
| Jun 2020 | - | -$16.01 M(+14.0%) | -$58.30 M(+14.3%) |
| Mar 2020 | - | -$14.04 M(-13.6%) | -$51.01 M(+4.9%) |
| Dec 2019 | -$48.63 M(+74.7%) | -$16.25 M(+35.4%) | -$48.63 M(+17.1%) |
| Sep 2019 | - | -$12.00 M(+37.7%) | -$41.54 M(+14.3%) |
| Jun 2019 | - | -$8.72 M(-25.3%) | -$36.34 M(+9.0%) |
| Mar 2019 | - | -$11.66 M(+27.4%) | -$33.36 M(+19.8%) |
| Dec 2018 | -$27.84 M | -$9.16 M(+34.5%) | -$27.84 M(+20.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$6.81 M(+18.8%) | -$23.16 M(+18.9%) |
| Jun 2018 | - | -$5.73 M(-6.8%) | -$19.48 M(+7.5%) |
| Mar 2018 | - | -$6.15 M(+37.3%) | -$18.12 M(-3.7%) |
| Dec 2017 | -$18.82 M(-24.0%) | -$4.48 M(+43.5%) | -$18.82 M(-7.7%) |
| Sep 2017 | - | -$3.12 M(-28.4%) | -$20.38 M(-14.1%) |
| Jun 2017 | - | -$4.36 M(-36.3%) | -$23.72 M(-7.1%) |
| Mar 2017 | - | -$6.85 M(+13.2%) | -$25.54 M(+3.1%) |
| Dec 2016 | -$24.77 M(+23.1%) | -$6.05 M(-6.4%) | -$24.77 M(+4.2%) |
| Sep 2016 | - | -$6.46 M(+4.5%) | -$23.77 M(+2.4%) |
| Jun 2016 | - | -$6.18 M(+1.6%) | -$23.21 M(+4.3%) |
| Mar 2016 | - | -$6.08 M(+20.5%) | -$22.26 M(+10.6%) |
| Dec 2015 | -$20.13 M(+134.4%) | -$5.05 M(-14.5%) | -$20.13 M(+18.1%) |
| Sep 2015 | - | -$5.90 M(+12.9%) | -$17.05 M(+19.6%) |
| Jun 2015 | - | -$5.23 M(+32.2%) | -$14.25 M(+24.9%) |
| Mar 2015 | - | -$3.95 M(+100.8%) | -$11.42 M(+32.9%) |
| Dec 2014 | -$8.59 M(+29.6%) | -$1.97 M(-36.7%) | -$8.59 M(-11.9%) |
| Sep 2014 | - | -$3.11 M(+30.1%) | -$9.75 M(+24.3%) |
| Jun 2014 | - | -$2.39 M(+112.4%) | -$7.84 M(+11.2%) |
| Mar 2014 | - | -$1.13 M(-64.0%) | -$7.05 M(+6.4%) |
| Dec 2013 | -$6.63 M(+439.6%) | -$3.13 M(+160.3%) | -$6.63 M(+89.3%) |
| Sep 2013 | - | -$1.20 M(-25.0%) | -$3.50 M(+52.2%) |
| Jun 2013 | - | -$1.60 M(+129.1%) | -$2.30 M(+229.1%) |
| Mar 2013 | - | -$699.00 K | -$699.00 K |
| Dec 2012 | -$1.23 M | - | - |
FAQ
- What is Marinus Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual CFO year-on-year change?
- What is Marinus Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly CFO year-on-year change?
- What is Marinus Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals TTM CFO year-on-year change?
What is Marinus Pharmaceuticals annual cash flow from operations?
The current annual CFO of MRNS is -$118.00 M
What is the all time high annual CFO for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual cash flow from operations is -$1.23 M
What is Marinus Pharmaceuticals annual CFO year-on-year change?
Over the past year, MRNS annual cash flow from operations has changed by -$5.12 M (-4.53%)
What is Marinus Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of MRNS is -$19.45 M
What is the all time high quarterly CFO for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly cash flow from operations is $5.40 M
What is Marinus Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, MRNS quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Marinus Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of MRNS is -$114.75 M
What is the all time high TTM CFO for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high TTM cash flow from operations is -$699.00 K
What is Marinus Pharmaceuticals TTM CFO year-on-year change?
Over the past year, MRNS TTM cash flow from operations has changed by $0.00 (0.00%)